Chiang J. Li,Mark A. Ashwell,Jason Hill,Magdi M. Moussa,Neru Munshi
申请号：
US13761712
公开号：
US20130150310A1
申请日:
2013.02.07
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention relates to pyrroloquinolinyl-pyrrolidine-2,5-dione compounds in combination with chemotherapeutic agents. The present invention provides methods of treating a cell proliferative disorder, such as a cancer, by administering to a subject in need thereof a therapeutically effective amount of a pyrroloquinolinyl-pyrrole-2,5-dione compound or pyrroloquinolinyl-pyrrolidine-2,5-dione compound of the present invention and also administering a effective amount of a chemotherapeutic agent.
